ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1Karin Enell Smith, Peter Ellmark|Cancer Immunology Immunotherapy|2023Cited by 8